Rockwell Medical Inc [RMTI] Revenue clocked in at $87.97 million, down -65.45% YTD: What’s Next?

Annabelle Farmer

Rockwell Medical Inc [NASDAQ: RMTI] slipped around -0.28 points on Thursday, while shares priced at $1.33 at the close of the session, down -17.39%.

Compared to the average trading volume of 1.25M shares, RMTI reached a trading volume of 4578441 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Rockwell Medical Inc [RMTI]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RMTI shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RMTI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Rodman & Renshaw have made an estimate for Rockwell Medical Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 14, 2024. While these analysts kept the previous recommendation, Piper Jaffray raised their target price to Overweight. The new note on the price target was released on June 24, 2019, representing the official price target for Rockwell Medical Inc stock. Previously, the target price had yet another raise to $11, while H.C. Wainwright analysts kept a Buy rating on RMTI stock.

The Price to Book ratio for the last quarter was 1.51, with the Price to Cash per share for the same quarter was set at 0.54. Price to Free Cash Flow for RMTI in the course of the last twelve months was 17.09 with Quick ratio for the last quarter at 2.51.

How has RMTI stock performed recently?

Rockwell Medical Inc [RMTI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -21.30. With this latest performance, RMTI shares gained by 26.67% in over the last four-week period, additionally sinking by -24.43% over the last 6 months – not to mention a drop of -34.80% in the past year of trading.

Rockwell Medical Inc [RMTI]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Rockwell Medical Inc [RMTI] shares currently have an operating margin of -1.47% and a Gross Margin at 17.52%. Rockwell Medical Inc’s Net Margin is presently recorded at -2.65%.

Rockwell Medical Inc (RMTI) Capital Structure & Debt Analysis

According to recent financial data for Rockwell Medical Inc. ( RMTI), the Return on Equity (ROE) stands at -8.65%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -4.41%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Rockwell Medical Inc’s Return on Invested Capital (ROIC) is -5.59%, showcasing its effectiveness in deploying capital for earnings.

Rockwell Medical Inc (RMTI) Efficiency & Liquidity Metrics

Based on Rockwell Medical Inc’s (RMTI) latest financial statements, the Debt-to-Equity Ratio is 0.46%, indicating its reliance on debt financing relative to shareholder equity.

Rockwell Medical Inc (RMTI) Efficiency & Liquidity Metrics

From an operational efficiency perspective, Rockwell Medical Inc. (RMTI) effectively leverages its workforce, generating an average of -$9549.18 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.89% and a Quick Ratio of 2.51%, indicating strong ability to cover short-term liabilities.

Earnings analysis for Rockwell Medical Inc [RMTI]

With the latest financial reports released by the company, Rockwell Medical Inc posted 0.05/share EPS, while the average EPS was predicted by analysts to be reported at 0.01/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.04. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RMTI.

Insider trade positions for Rockwell Medical Inc [RMTI]

There are presently around $17.19%, or 19.92%% of RMTI stock, in the hands of institutional investors. The top three institutional holders of RMTI stocks are: ARMISTICE CAPITAL, LLC with ownership of 3.22 million shares, which is approximately 10.5795%. VANGUARD GROUP INC, holding 1.12 million shares of the stock with an approximate value of $$1.97 million in RMTI stocks shares; and VANGUARD GROUP INC, currently with $$0.62 million in RMTI stock with ownership which is approximately 1.1507%.

DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.